Research programme: small molecules therapeutics - Evotec SE/Janssen Pharmaceutica
Latest Information Update: 24 Jun 2022
At a glance
- Originator Evotec SE; Janssen Pharmaceutica
- Developer Evotec SE
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified